<li>5-htp<p>5-htp and dextroamphetamine both increase  serotonin levels. Use Caution/Monitor.</p></li><li>acebutolol<p>amphetamine decreases effects of acebutolol by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>acetazolamide<p>acetazolamide will increase the level or effect of dextroamphetamine by  passive renal tubular reabsorption - basic urine. Use Caution/Monitor.</p></li><li>albuterol<p>albuterol and dextroamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>albuterol and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.<span><br><br></span>amphetamine, albuterol.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.</p></li><li>alfentanil<p>alfentanil increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>aliskiren<p>amphetamine decreases effects of aliskiren by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>almotriptan<p>almotriptan and dextroamphetamine both increase  serotonin levels. Use Caution/Monitor.<span><br><br></span>amphetamine increases toxicity of almotriptan by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>alprazolam<p>alprazolam increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>amiloride<p>amphetamine decreases effects of amiloride by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>aluminum hydroxide<p>aluminum hydroxide will increase the level or effect of dextroamphetamine by  passive renal tubular reabsorption - basic urine. Use Caution/Monitor.</p></li><li>amisulpride<p>amisulpride increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>amitriptyline<p>amphetamine increases toxicity of amitriptyline by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).<span><br><br></span>amitriptyline increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>amphetamine increases effects of amitriptyline by unspecified interaction mechanism. Modify Therapy/Monitor Closely. Combination may cause sustained increases in the concentration of d- amphetamine in the brain; cardiovascular effects can be potentiated.<span><br><br></span>amitriptyline increases effects of dextroamphetamine by unknown mechanism. Use Caution/Monitor.<span><br><br></span>amitriptyline and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>amlodipine<p>amphetamine decreases effects of amlodipine by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>ammonium chloride<p>ammonium chloride decreases levels of dextroamphetamine by increasing renal clearance. Use Caution/Monitor.</p></li><li>ammonium chloride<p>ammonium chloride decreases levels of amphetamine by passive renal tubular reabsorption due to decreased pH. Use Caution/Monitor. Basic amphetamine molecule is ionized by acidic pH, thus preventing renal tubular reabsorption.</p></li><li>amobarbital<p>amobarbital increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>amoxapine<p>amoxapine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>amphetamine increases toxicity of amoxapine by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).<span><br><br></span>amoxapine increases effects of dextroamphetamine by unknown mechanism. Use Caution/Monitor.<span><br><br></span>amoxapine and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>amphetamine increases effects of amoxapine by unspecified interaction mechanism. Modify Therapy/Monitor Closely. Combination may cause sustained increases in the concentration of d- amphetamine in the brain; cardiovascular effects can be potentiated.</p></li><li>arformoterol<p>arformoterol and dextroamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>amphetamine, arformoterol.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.<span><br><br></span>arformoterol and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>aripiprazole<p>aripiprazole increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>ascorbic acid<p>ascorbic acid decreases levels of amphetamine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Basic amphetamine molecule is ionized by acidic pH, thus lowering GI absorption.</p></li><li>armodafinil<p>armodafinil and dextroamphetamine both decrease  sedation. Use Caution/Monitor.</p></li><li>artemether/lumefantrine<p>artemether/lumefantrine will increase the level or effect of dextroamphetamine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>azelastine<p>azelastine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>azilsartan<p>amphetamine decreases effects of azilsartan by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>bambuterol<p>bambuterol and dextroamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>bambuterol and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>belladonna and opium<p>belladonna and opium increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>benazepril<p>amphetamine decreases effects of benazepril by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>dextroamphetamine decreases effects of benazepril by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>bendroflumethiazide<p>amphetamine decreases effects of bendroflumethiazide by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>benperidol<p>benperidol increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>benzphetamine<p>dextroamphetamine and benzphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>benzphetamine and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>bromocriptine<p>bromocriptine, dextroamphetamine.
Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Hypertension, V tach.</p></li><li>brompheniramine<p>brompheniramine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>bumetanide<p>amphetamine decreases effects of bumetanide by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>buprenorphine<p>amphetamine increases effects of buprenorphine by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.</p></li><li>buprenorphine buccal<p>amphetamine increases effects of buprenorphine buccal by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.<span><br><br></span>buprenorphine buccal increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>buprenorphine subdermal implant<p>dextroamphetamine, buprenorphine subdermal implant.
Either increases toxicity of the other by serotonin levels. Use Caution/Monitor. Concomitant use could result in life-threatening serotonin syndrome. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation, and during dose adjustment of the serotonergic drug. Discontinue buprenorphine if serotonin syndrome is suspected.<span><br><br></span>amphetamine, buprenorphine subdermal implant.
Either increases toxicity of the other by serotonin levels. Use Caution/Monitor. Concomitant use could result in life-threatening serotonin syndrome. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation, and during dose adjustment of the serotonergic drug. Discontinue buprenorphine if serotonin syndrome is suspected.</p></li><li>buprenorphine transdermal<p>amphetamine increases effects of buprenorphine transdermal by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.</p></li><li>bupropion<p>bupropion will increase the level or effect of dextroamphetamine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>dextroamphetamine increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>bupropion<p>amphetamine increases toxicity of bupropion by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>buspirone<p>buspirone and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>butabarbital<p>butabarbital increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>butalbital<p>butalbital increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>butorphanol<p>amphetamine increases effects of butorphanol by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.<span><br><br></span>butorphanol increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>caffeine<p>caffeine and dextroamphetamine both decrease  sedation. Use Caution/Monitor.</p></li><li>candesartan<p>amphetamine decreases effects of candesartan by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>calcium carbonate<p>calcium carbonate will increase the level or effect of dextroamphetamine by  passive renal tubular reabsorption - basic urine. Use Caution/Monitor.</p></li><li>captopril<p>dextroamphetamine decreases effects of captopril by pharmacodynamic antagonism. Use Caution/Monitor. Dextroamphetamine may decrease the antihypertensive effects of ACE Inhibitors.<span><br><br></span>amphetamine decreases effects of captopril by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>carbinoxamine<p>carbinoxamine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>carvedilol<p>amphetamine decreases effects of carvedilol by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>chloral hydrate<p>chloral hydrate increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>chlordiazepoxide<p>chlordiazepoxide increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>chlorothiazide<p>amphetamine decreases effects of chlorothiazide by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>chlorpheniramine<p>chlorpheniramine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>chlorpromazine<p>chlorpromazine decreases effects of amphetamine by Other (see comment). Use Caution/Monitor. 
Comment: Chlorpromazine blocks dopamine and norepinephrine reuptake, thus inhibiting the central stimulant effects of amphetamine. This is sometimes used to treat amphetamine poisoning.<span><br><br></span>chlorpromazine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>chlorpromazine, dextroamphetamine. Mechanism: unknown. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines.  Interaction more likely in certain predisposed pts. only.</p></li><li>chlorthalidone<p>amphetamine decreases effects of chlorthalidone by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>cinnarizine<p>cinnarizine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>citalopram<p>citalopram and dextroamphetamine both increase  serotonin levels. Use Caution/Monitor. Combination may increase risk of serotonin syndrome or neuroleptic malignant syndrome-like reactions.<span><br><br></span>amphetamine increases toxicity of citalopram by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>clemastine<p>clemastine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>clevidipine<p>amphetamine decreases effects of clevidipine by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>clomethiazole<p>clomethiazole increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>clomipramine<p>clomipramine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>amphetamine increases toxicity of clomipramine by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).<span><br><br></span>clomipramine and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>clomipramine increases effects of dextroamphetamine by unknown mechanism. Use Caution/Monitor.<span><br><br></span>amphetamine increases effects of clomipramine by unspecified interaction mechanism. Modify Therapy/Monitor Closely. Combination may cause sustained increases in the concentration of d- amphetamine in the brain; cardiovascular effects can be potentiated.</p></li><li>clonazepam<p>clonazepam increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>codeine<p>amphetamine increases effects of codeine by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.</p></li><li>clorazepate<p>clorazepate increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>clozapine<p>clozapine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>cocaine<p>cocaine and dextroamphetamine both increase  serotonin levels. Use Caution/Monitor.</p></li><li>codeine<p>codeine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>cyclizine<p>cyclizine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>cyclobenzaprine<p>amphetamine increases toxicity of cyclobenzaprine by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>cyproheptadine<p>cyproheptadine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>dextroamphetamine increases and cyproheptadine decreases serotonin levels. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>desipramine<p>desipramine and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>desipramine increases effects of dextroamphetamine by unknown mechanism. Use Caution/Monitor.<span><br><br></span>amphetamine increases effects of desipramine by unspecified interaction mechanism. Modify Therapy/Monitor Closely. Combination may cause sustained increases in the concentration of d- amphetamine in the brain; cardiovascular effects can be potentiated.<span><br><br></span>desipramine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>amphetamine increases toxicity of desipramine by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>desvenlafaxine<p>desvenlafaxine will increase the level or effect of dextroamphetamine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor. Desvenlafaxine inhibits CYP2D6; with higher desvenlafaxine doses (ie, 400 mg) decrease the CYP2D6 substrate dose by up to 50%; no dosage adjustment needed with desvenlafaxine doses &lt;100 mg<span><br><br></span>amphetamine increases toxicity of desvenlafaxine by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>dexchlorpheniramine<p>dexchlorpheniramine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>diltiazem<p>amphetamine decreases effects of diltiazem by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>dexfenfluramine<p>dextroamphetamine and dexfenfluramine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>dexfenfluramine and dextroamphetamine both increase  serotonin levels. Use Caution/Monitor.<span><br><br></span>dexfenfluramine and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>dexlansoprazole<p>dexlansoprazole, dextroamphetamine. Other (see comment). Use Caution/Monitor. 
Comment: Reduced gastric acidity caused by proton pump inhibitors decreases time to Tmax for amphetamine and dextroamphetamine. AUC was unaffected. .</p></li><li>dexmedetomidine<p>dexmedetomidine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dexmethylphenidate<p>dexmethylphenidate and dextroamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>dexmethylphenidate and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>dextromethorphan<p>dextroamphetamine and dextromethorphan both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>dextromoramide<p>dextromoramide increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>diamorphine<p>diamorphine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>diethylpropion<p>dextroamphetamine and diethylpropion both decrease  sedation. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and diethylpropion both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>difenoxin hcl<p>difenoxin hcl increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dihydroergotamine<p>dextroamphetamine and dihydroergotamine both increase  serotonin levels. Use Caution/Monitor.</p></li><li>dihydroergotamine intranasal<p>dextroamphetamine and dihydroergotamine intranasal both increase  serotonin levels. Use Caution/Monitor.</p></li><li>dimenhydrinate<p>dimenhydrinate increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>diphenhydramine<p>diphenhydramine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>diphenoxylate hcl<p>diphenoxylate hcl increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dipipanone<p>dipipanone increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dobutamine<p>dobutamine and dextroamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>dobutamine and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>dolasetron<p>amphetamine increases toxicity of dolasetron by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>dopamine<p>dextroamphetamine and dopamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and dopamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>dopexamine<p>dopexamine and dextroamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>dopexamine and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>dosulepin<p>dosulepin increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>dosulepin and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>dosulepin increases effects of dextroamphetamine by unknown mechanism. Use Caution/Monitor.</p></li><li>doxepin<p>doxepin increases effects of dextroamphetamine by unknown mechanism. Use Caution/Monitor.<span><br><br></span>doxepin and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>doxepin increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>amphetamine increases effects of doxepin by unspecified interaction mechanism. Modify Therapy/Monitor Closely. Combination may cause sustained increases in the concentration of d- amphetamine in the brain; cardiovascular effects can be potentiated.<span><br><br></span>amphetamine increases toxicity of doxepin by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>droperidol<p>droperidol increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>droxidopa<p>amphetamine, droxidopa.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.</p></li><li>droxidopa<p>dextroamphetamine and droxidopa both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. May increase risk for supine hypertension</p></li><li>duloxetine<p>amphetamine increases toxicity of duloxetine by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).<span><br><br></span>duloxetine and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>duloxetine will increase the level or effect of dextroamphetamine by  affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely.</p></li><li>eletriptan<p>eletriptan and dextroamphetamine both increase  serotonin levels. Use Caution/Monitor.<span><br><br></span>amphetamine increases toxicity of eletriptan by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>enalapril<p>amphetamine decreases effects of enalapril by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>enflurane<p>enflurane increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.  .</p></li><li>ephedrine<p>ephedrine and dextroamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>amphetamine, ephedrine.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.<span><br><br></span>ephedrine and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>ephedrine (pulmonary)<p>ephedrine (pulmonary) and dextroamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>amphetamine, ephedrine (pulmonary).
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.<span><br><br></span>ephedrine (pulmonary) and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>epinephrine<p>amphetamine, epinephrine.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.<span><br><br></span>epinephrine and dextroamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>epinephrine and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>epinephrine racemic<p>epinephrine racemic and dextroamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>amphetamine, epinephrine racemic.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.<span><br><br></span>epinephrine racemic and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>eprosartan<p>amphetamine decreases effects of eprosartan by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>ergotamine<p>dextroamphetamine and ergotamine both increase  serotonin levels. Use Caution/Monitor.</p></li><li>escitalopram<p>escitalopram and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>amphetamine increases toxicity of escitalopram by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>esomeprazole<p>esomeprazole, dextroamphetamine. Other (see comment). Use Caution/Monitor. 
Comment: Reduced gastric acidity caused by proton pump inhibitors decreases time to Tmax for amphetamine and dextroamphetamine. AUC was unaffected. .</p></li><li>ethacrynic acid<p>amphetamine decreases effects of ethacrynic acid by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>estazolam<p>estazolam increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>ethanol<p>ethanol increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>ethosuximide<p>amphetamine, ethosuximide. Other (see comment). Use Caution/Monitor. 
Comment: Amphetamines may delay intestinal absorption of ethosuximide.</p></li><li>felodipine<p>amphetamine decreases effects of felodipine by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>fenfluramine<p>dextroamphetamine and fenfluramine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and fenfluramine both increase  serotonin levels. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and fenfluramine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>fentanyl<p>amphetamine increases effects of fentanyl by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.</p></li><li>fentanyl intranasal<p>amphetamine increases effects of fentanyl intranasal by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.</p></li><li>fentanyl iontophoretic transdermal system<p>amphetamine increases effects of fentanyl iontophoretic transdermal system by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.</p></li><li>fentanyl transdermal<p>amphetamine increases effects of fentanyl transdermal by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.</p></li><li>fentanyl transmucosal<p>amphetamine increases effects of fentanyl transmucosal by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.</p></li><li>fluoxetine<p>amphetamine increases toxicity of fluoxetine by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).<span><br><br></span>fluoxetine will increase the level or effect of dextroamphetamine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>fluoxetine and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>fluphenazine<p>fluphenazine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>fluphenazine, dextroamphetamine. Mechanism: unknown. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines.  Interaction more likely in certain predisposed pts. only.</p></li><li>fluvoxamine<p>amphetamine increases toxicity of fluvoxamine by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>flurazepam<p>flurazepam increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>fluvoxamine<p>fluvoxamine and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>formoterol<p>formoterol and dextroamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>formoterol and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.<span><br><br></span>amphetamine, formoterol.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.</p></li><li>fosinopril<p>amphetamine decreases effects of fosinopril by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>frovatriptan<p>frovatriptan and dextroamphetamine both increase  serotonin levels. Use Caution/Monitor.</p></li><li>frovatriptan<p>amphetamine increases toxicity of frovatriptan by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>furosemide<p>amphetamine decreases effects of furosemide by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>granisetron<p>amphetamine increases toxicity of granisetron by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>grapefruit<p>grapefruit decreases levels of amphetamine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Basic amphetamine molecule is ionized by acidic pH of grapefruit or acidic juices, thus lowering GI absorption.</p></li><li>green tea<p>green tea, dextroamphetamine. Other (see comment). Use Caution/Monitor. 
Comment: Green tea may include caffeine. Caffeine is a CNS-stimulant and additive effects may be seen when coadministered with other CNS stimulants. Caffeine should be avoided or used cautiously.</p></li><li>haloperidol<p>haloperidol decreases effects of amphetamine by Other (see comment). Use Caution/Monitor. 
Comment: Haloperidol blocks dopamine and norepinephrine reuptake, thus inhibiting the central stimulant effects of amphetamine. .<span><br><br></span>haloperidol increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>hexobarbital<p>hexobarbital increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>hydrochlorothiazide<p>amphetamine decreases effects of hydrochlorothiazide by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>hydralazine<p>hydralazine, dextroamphetamine. Mechanism: pharmacodynamic antagonism. Use Caution/Monitor. Sympathomimetics can antagonize the activity of some antihypertensive agents.</p></li><li>hydrocodone<p>amphetamine increases effects of hydrocodone by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.<span><br><br></span>hydrocodone increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>hydromorphone<p>amphetamine increases effects of hydromorphone by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.<span><br><br></span>hydromorphone increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>hydroxyzine<p>hydroxyzine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>imipramine<p>amphetamine increases effects of imipramine by unspecified interaction mechanism. Modify Therapy/Monitor Closely. Combination may cause sustained increases in the concentration of d- amphetamine in the brain; cardiovascular effects can be potentiated.<span><br><br></span>amphetamine increases toxicity of imipramine by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>iloperidone<p>iloperidone increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>imipramine<p>imipramine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>imipramine and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>imipramine increases effects of dextroamphetamine by unknown mechanism. Use Caution/Monitor.</p></li><li>indacaterol, inhaled<p>amphetamine, indacaterol, inhaled.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.</p></li><li>indapamide<p>amphetamine decreases effects of indapamide by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>ioflupane i 123<p>dextroamphetamine decreases effects of ioflupane i 123 by receptor binding competition. Use Caution/Monitor. Drugs that bind to dopamine transporter receptor with high affinity may interfere with the image following ioflupane I 123 administration.</p></li><li>irbesartan<p>amphetamine decreases effects of irbesartan by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>isocarboxazid<p>amphetamine increases toxicity of isocarboxazid by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>isoniazid<p>dextroamphetamine and isoniazid both increase  serotonin levels. Use Caution/Monitor.</p></li><li>isoproterenol<p>isoproterenol and dextroamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>isoproterenol and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>isradipine<p>amphetamine decreases effects of isradipine by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>ketotifen, ophthalmic<p>ketotifen, ophthalmic increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>l-tryptophan<p>dextroamphetamine and l-tryptophan both increase  serotonin levels. Use Caution/Monitor.</p></li><li>labetalol<p>amphetamine decreases effects of labetalol by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>lansoprazole<p>lansoprazole, dextroamphetamine. Other (see comment). Use Caution/Monitor. 
Comment: Reduced gastric acidity caused by proton pump inhibitors decreases time to Tmax for amphetamine and dextroamphetamine. AUC was unaffected. .</p></li><li>levalbuterol<p>levalbuterol and dextroamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>amphetamine, levalbuterol.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.<span><br><br></span>levalbuterol and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>levomilnacipran<p>amphetamine increases toxicity of levomilnacipran by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).<span><br><br></span>levomilnacipran and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>levorphanol<p>amphetamine increases effects of levorphanol by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.<span><br><br></span>levorphanol increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>linezolid<p>amphetamine increases toxicity of linezolid by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>lisdexamfetamine<p>dextroamphetamine and lisdexamfetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and lisdexamfetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>lisinopril<p>amphetamine decreases effects of lisinopril by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>lithium<p>lithium decreases effects of amphetamine by unspecified interaction mechanism. Use Caution/Monitor. Lithium may inhibit the antiobesity and stimulatory effects of amphentamines.<span><br><br></span>dextroamphetamine and lithium both increase  serotonin levels. Use Caution/Monitor.<span><br><br></span>amphetamine increases toxicity of lithium by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>lofepramine<p>lofepramine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>lofepramine and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>lofepramine increases effects of dextroamphetamine by unknown mechanism. Use Caution/Monitor.</p></li><li>losartan<p>amphetamine decreases effects of losartan by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>lofexidine<p>lofexidine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>loprazolam<p>loprazolam increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>lorazepam<p>lorazepam increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>lormetazepam<p>lormetazepam increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>loxapine<p>loxapine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>loxapine inhaled<p>loxapine inhaled increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>lsd<p>dextroamphetamine and lsd both increase  serotonin levels. Use Caution/Monitor.</p></li><li>lumefantrine<p>lumefantrine will increase the level or effect of dextroamphetamine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>maprotiline<p>maprotiline increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>maprotiline and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>maprotiline increases effects of dextroamphetamine by unknown mechanism. Use Caution/Monitor.</p></li><li>marijuana<p>marijuana increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>melatonin<p>melatonin increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>meperidine<p>meperidine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>amphetamine increases effects of meperidine by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.<span><br><br></span>dextroamphetamine and meperidine both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>amphetamine increases toxicity of meperidine by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>mephobarbital<p>mephobarbital increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>metaproterenol<p>amphetamine, metaproterenol.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.</p></li><li>meprobamate<p>meprobamate increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>metaproterenol<p>metaproterenol and dextroamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>metaproterenol and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>methadone<p>methadone increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>amphetamine increases effects of methadone by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.</p></li><li>methamphetamine<p>dextroamphetamine and methamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and methamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>methenamine<p>methenamine decreases levels of amphetamine by passive renal tubular reabsorption due to decreased pH. Use Caution/Monitor. Hippuric acid, a component of methenamine therapy, is used to maintain an acidic urinary pH. The basic amphetamine molecule is ionized by acidic pH, thus preventing renal tubular reabsorption.</p></li><li>methyclothiazide<p>amphetamine decreases effects of methyclothiazide by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>methyldopa<p>methyldopa increases effects of dextroamphetamine by unknown mechanism. Use Caution/Monitor.</p></li><li>methylene blue<p>amphetamine increases toxicity of methylene blue by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>methylenedioxymethamphetamine<p>dextroamphetamine and methylenedioxymethamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and methylenedioxymethamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>methylphenidate<p>dextroamphetamine and methylphenidate both decrease  sedation. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and methylphenidate both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>metolazone<p>amphetamine decreases effects of metolazone by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>mianserin<p>mianserin increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>mianserin and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>mianserin increases effects of dextroamphetamine by unknown mechanism. Use Caution/Monitor.</p></li><li>midazolam<p>midazolam increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>midodrine<p>dextroamphetamine and midodrine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and midodrine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>milnacipran<p>milnacipran and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>amphetamine increases toxicity of milnacipran by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>mirtazapine<p>mirtazapine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and mirtazapine both increase  serotonin levels. Use Caution/Monitor.<span><br><br></span>amphetamine increases toxicity of mirtazapine by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>modafinil<p>dextroamphetamine and modafinil both decrease  sedation. Use Caution/Monitor.</p></li><li>moexipril<p>amphetamine decreases effects of moexipril by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>morphine<p>amphetamine increases effects of morphine by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.<span><br><br></span>morphine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and morphine both increase  serotonin levels. Use Caution/Monitor.</p></li><li>motherwort<p>motherwort increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>nadolol<p>amphetamine decreases effects of nadolol by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>moxonidine<p>moxonidine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>nabilone<p>nabilone increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>nalbuphine<p>amphetamine increases effects of nalbuphine by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.<span><br><br></span>nalbuphine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>naratriptan<p>naratriptan and dextroamphetamine both increase  serotonin levels. Use Caution/Monitor.<span><br><br></span>amphetamine increases toxicity of naratriptan by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>nefazodone<p>amphetamine increases toxicity of nefazodone by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).<span><br><br></span>nefazodone and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>nicardipine<p>amphetamine decreases effects of nicardipine by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>norepinephrine<p>norepinephrine and dextroamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>norepinephrine and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>nifedipine<p>amphetamine decreases effects of nifedipine by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>nimodipine<p>amphetamine decreases effects of nimodipine by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>nisoldipine<p>amphetamine decreases effects of nisoldipine by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>norepinephrine<p>amphetamine, norepinephrine.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.</p></li><li>nortriptyline<p>nortriptyline increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>amphetamine increases effects of nortriptyline by unspecified interaction mechanism. Modify Therapy/Monitor Closely. Combination may cause sustained increases in the concentration of d- amphetamine in the brain; cardiovascular effects can be potentiated.<span><br><br></span>nortriptyline increases effects of dextroamphetamine by unknown mechanism. Use Caution/Monitor.<span><br><br></span>amphetamine increases toxicity of nortriptyline by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).<span><br><br></span>nortriptyline and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>olanzapine<p>olanzapine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>olmesartan<p>amphetamine decreases effects of olmesartan by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>olodaterol inhaled<p>amphetamine, olodaterol inhaled.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.</p></li><li>omeprazole<p>omeprazole, dextroamphetamine. Other (see comment). Use Caution/Monitor. 
Comment: Reduced gastric acidity caused by proton pump inhibitors decreases time to Tmax for amphetamine and dextroamphetamine. AUC was unaffected. .</p></li><li>ondansetron<p>amphetamine increases toxicity of ondansetron by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>opium tincture<p>opium tincture increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>oxazepam<p>oxazepam increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>oxycodone<p>amphetamine increases effects of oxycodone by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.<span><br><br></span>oxycodone increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>oxymorphone<p>amphetamine increases effects of oxymorphone by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.<span><br><br></span>oxymorphone increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>oxytocin<p>oxytocin increases effects of dextroamphetamine by pharmacodynamic synergism. Use Caution/Monitor.</p></li><li>palonosetron<p>amphetamine increases toxicity of palonosetron by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>paliperidone<p>paliperidone increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>pantoprazole<p>pantoprazole, dextroamphetamine. Other (see comment). Use Caution/Monitor. 
Comment: Reduced gastric acidity caused by proton pump inhibitors decreases time to Tmax for amphetamine and dextroamphetamine. AUC was unaffected. .</p></li><li>papaveretum<p>papaveretum increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>paroxetine<p>amphetamine increases toxicity of paroxetine by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).<span><br><br></span>paroxetine and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>paroxetine will increase the level or effect of dextroamphetamine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>penbutolol<p>amphetamine decreases effects of penbutolol by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>pentazocine<p>pentazocine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and pentazocine both increase  serotonin levels. Use Caution/Monitor.</p></li><li>pentazocine<p>amphetamine increases effects of pentazocine by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.</p></li><li>pentobarbital<p>pentobarbital increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>perindopril<p>amphetamine decreases effects of perindopril by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>perphenazine<p>perphenazine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>perphenazine, dextroamphetamine. Mechanism: unknown. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines.  Interaction more likely in certain predisposed pts. only.</p></li><li>phendimetrazine<p>dextroamphetamine and phendimetrazine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and phendimetrazine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>phenelzine<p>amphetamine increases toxicity of phenelzine by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>phenobarbital<p>amphetamine, phenobarbital. Other (see comment). Use Caution/Monitor. 
Comment: Amphetamines may delay intestinal absorption of phenobarbital.<span><br><br></span>phenobarbital increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>phenoxybenzamine<p>amphetamine decreases effects of phenoxybenzamine by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>phentermine<p>dextroamphetamine and phentermine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and phentermine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>phentolamine<p>amphetamine decreases effects of phentolamine by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>phenylephrine<p>dextroamphetamine and phenylephrine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and phenylephrine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>phenylephrine po<p>dextroamphetamine and phenylephrine po both decrease  sedation. Use Caution/Monitor.<span><br><br></span>amphetamine, phenylephrine po.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.<span><br><br></span>dextroamphetamine and phenylephrine po both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>phenytoin<p>amphetamine, phenytoin. Other (see comment). Use Caution/Monitor. 
Comment: Amphetamines may delay intestinal absorption of phenytoin.</p></li><li>pholcodine<p>pholcodine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>pimozide<p>pimozide increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>pindolol<p>amphetamine decreases effects of pindolol by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>pirbuterol<p>amphetamine, pirbuterol.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.<span><br><br></span>pirbuterol and dextroamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>pirbuterol and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>prazosin<p>amphetamine decreases effects of prazosin by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>primidone<p>primidone increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>prochlorperazine<p>prochlorperazine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>prochlorperazine, dextroamphetamine. Mechanism: unknown. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines.  Interaction more likely in certain predisposed pts. only.</p></li><li>promazine<p>promazine, dextroamphetamine. Mechanism: unknown. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines.  Interaction more likely in certain predisposed pts. only.</p></li><li>promethazine<p>promethazine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>promethazine, dextroamphetamine. Mechanism: unknown. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines.  Interaction more likely in certain predisposed pts. only.</p></li><li>propranolol<p>amphetamine decreases effects of propranolol by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>propylhexedrine<p>dextroamphetamine and propylhexedrine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and propylhexedrine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>protriptyline<p>amphetamine increases effects of protriptyline by unspecified interaction mechanism. Modify Therapy/Monitor Closely. Combination may cause sustained increases in the concentration of d- amphetamine in the brain; cardiovascular effects can be potentiated.<span><br><br></span>protriptyline increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>protriptyline and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>amphetamine increases toxicity of protriptyline by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).<span><br><br></span>protriptyline increases effects of dextroamphetamine by unknown mechanism. Use Caution/Monitor.</p></li><li>pseudoephedrine<p>dextroamphetamine and pseudoephedrine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and pseudoephedrine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>amphetamine, pseudoephedrine.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.</p></li><li>quazepam<p>quazepam increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>quinapril<p>amphetamine decreases effects of quinapril by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>quetiapine<p>quetiapine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>quinidine<p>quinidine will increase the level or effect of dextroamphetamine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>rabeprazole<p>rabeprazole, dextroamphetamine. Other (see comment). Use Caution/Monitor. 
Comment: Reduced gastric acidity caused by proton pump inhibitors decreases time to Tmax for amphetamine and dextroamphetamine. AUC was unaffected. .</p></li><li>ramipril<p>amphetamine decreases effects of ramipril by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>rasagiline<p>amphetamine increases toxicity of rasagiline by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>remifentanil<p>amphetamine increases effects of remifentanil by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.</p></li><li>reserpine<p>reserpine decreases levels of amphetamine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Basic amphetamine molecule is ionized by acidic pH, thus lowering GI absorption.</p></li><li>risperidone<p>risperidone increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>rizatriptan<p>amphetamine increases toxicity of rizatriptan by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).<span><br><br></span>rizatriptan and dextroamphetamine both increase  serotonin levels. Use Caution/Monitor.</p></li><li>sacubitril/valsartan<p>amphetamine decreases effects of sacubitril/valsartan by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>salmeterol<p>salmeterol and dextroamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>salmeterol and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>salmeterol<p>amphetamine, salmeterol.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.</p></li><li>same<p>dextroamphetamine and same both increase  serotonin levels. Use Caution/Monitor.</p></li><li>scullcap<p>scullcap increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>secobarbital<p>secobarbital increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>selegiline<p>amphetamine increases toxicity of selegiline by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>selegiline transdermal<p>amphetamine increases toxicity of selegiline transdermal by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).<span><br><br></span>selegiline transdermal and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>sertindole<p>sertindole increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>sertraline<p>amphetamine increases toxicity of sertraline by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>sertraline<p>sertraline will increase the level or effect of dextroamphetamine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>sertraline and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>shepherd's purse<p>shepherd's purse increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>sodium acid phosphate<p>sodium acid phosphate decreases levels of amphetamine by passive renal tubular reabsorption due to decreased pH. Use Caution/Monitor. Basic amphetamine molecule is ionized by acidic pH, thus preventing renal tubular reabsorption.<span><br><br></span>sodium acid phosphate decreases levels of dextroamphetamine by increasing renal clearance. Use Caution/Monitor.</p></li><li>sodium bicarbonate<p>sodium bicarbonate will increase the level or effect of dextroamphetamine by  passive renal tubular reabsorption - basic urine. Use Caution/Monitor.</p></li><li>sotalol<p>amphetamine decreases effects of sotalol by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>sodium citrate/citric acid<p>sodium citrate/citric acid will increase the level or effect of dextroamphetamine by  passive renal tubular reabsorption - basic urine. Use Caution/Monitor.</p></li><li>sodium lactate<p>sodium lactate will increase the level or effect of dextroamphetamine by  passive renal tubular reabsorption - basic urine. Use Caution/Monitor.</p></li><li>spironolactone<p>amphetamine decreases effects of spironolactone by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>st john's wort<p>dextroamphetamine and st john's wort both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>amphetamine increases toxicity of st john's wort by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>sufentanil<p>sufentanil increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>amphetamine increases effects of sufentanil by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.</p></li><li>sufentanil sl<p>amphetamine increases effects of sufentanil sl by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.</p></li><li>sulpiride<p>sulpiride increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>sumatriptan<p>amphetamine increases toxicity of sumatriptan by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).<span><br><br></span>sumatriptan and dextroamphetamine both increase  serotonin levels. Use Caution/Monitor.</p></li><li>sumatriptan intranasal<p>amphetamine increases toxicity of sumatriptan intranasal by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).<span><br><br></span>sumatriptan intranasal and dextroamphetamine both increase  serotonin levels. Use Caution/Monitor.</p></li><li>sumatriptan transdermal<p>amphetamine increases toxicity of sumatriptan transdermal by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).<span><br><br></span>sumatriptan transdermal and dextroamphetamine both increase  serotonin levels. Use Caution/Monitor.</p></li><li>tapentadol<p>amphetamine increases toxicity of tapentadol by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).<span><br><br></span>tapentadol increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>amphetamine increases effects of tapentadol by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.</p></li><li>telmisartan<p>amphetamine decreases effects of telmisartan by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>temazepam<p>temazepam increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>terazosin<p>amphetamine decreases effects of terazosin by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>terbutaline<p>terbutaline and dextroamphetamine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>amphetamine, terbutaline.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.<span><br><br></span>terbutaline and dextroamphetamine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>terfenadine<p>terfenadine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>timolol<p>amphetamine decreases effects of timolol by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>thioridazine<p>thioridazine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>thioridazine, dextroamphetamine. Mechanism: unknown. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines.  Interaction more likely in certain predisposed pts. only.</p></li><li>thiothixene<p>thiothixene increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>topiramate<p>topiramate increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>torsemide<p>amphetamine decreases effects of torsemide by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>tramadol<p>dextroamphetamine and tramadol both increase  serotonin levels. Use Caution/Monitor.<span><br><br></span>amphetamine increases toxicity of tramadol by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).<span><br><br></span>amphetamine increases effects of tramadol by unspecified interaction mechanism. Use Caution/Monitor. Amphetamines may enhance the analgesic effects of opioid analgesics.<span><br><br></span>tramadol increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>trandolapril<p>amphetamine decreases effects of trandolapril by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>trazodone<p>trazodone increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>trazodone and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>trazodone increases effects of dextroamphetamine by unknown mechanism. Use Caution/Monitor.</p></li><li>tranylcypromine<p>amphetamine increases toxicity of tranylcypromine by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>trazodone<p>amphetamine increases toxicity of trazodone by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>triamterene<p>amphetamine decreases effects of triamterene by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>triazolam<p>triazolam increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>triclofos<p>triclofos increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>trifluoperazine<p>trifluoperazine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>trifluoperazine, dextroamphetamine. Mechanism: unknown. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines.  Interaction more likely in certain predisposed pts. only.</p></li><li>trimipramine<p>amphetamine increases effects of trimipramine by unspecified interaction mechanism. Modify Therapy/Monitor Closely. Combination may cause sustained increases in the concentration of d- amphetamine in the brain; cardiovascular effects can be potentiated.<span><br><br></span>trimipramine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>trimipramine increases effects of dextroamphetamine by unknown mechanism. Use Caution/Monitor.<span><br><br></span>amphetamine increases toxicity of trimipramine by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).<span><br><br></span>trimipramine and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>umeclidinium bromide/vilanterol inhaled<p>amphetamine, umeclidinium bromide/vilanterol inhaled.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.</p></li><li>venlafaxine<p>venlafaxine will increase the level or effect of dextroamphetamine by  affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely.<span><br><br></span>venlafaxine and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>valsartan<p>amphetamine decreases effects of valsartan by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>venlafaxine<p>amphetamine increases toxicity of venlafaxine by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>verapamil<p>amphetamine decreases effects of verapamil by pharmacodynamic antagonism. Use Caution/Monitor.<span><br><br></span>amphetamine increases toxicity of verapamil by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>vilanterol/fluticasone furoate inhaled<p>amphetamine, vilanterol/fluticasone furoate inhaled.
Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely.</p></li><li>vilazodone<p>amphetamine increases toxicity of vilazodone by serum potassium. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>vortioxetine<p>amphetamine increases toxicity of vortioxetine by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>xylometazoline<p>dextroamphetamine and xylometazoline both decrease  sedation. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and xylometazoline both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>yohimbine<p>dextroamphetamine and yohimbine both decrease  sedation. Use Caution/Monitor.<span><br><br></span>dextroamphetamine and yohimbine both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.</p></li><li>ziconotide<p>ziconotide increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>ziprasidone<p>ziprasidone increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>zolmitriptan<p>zolmitriptan and dextroamphetamine both increase  serotonin levels. Use Caution/Monitor.<span><br><br></span>amphetamine increases toxicity of zolmitriptan by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>zotepine<p>zotepine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li>